USE OF ROSMARINIC ACID IN MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING HEPATIC AND RENAL DISEASES
    9.
    发明申请
    USE OF ROSMARINIC ACID IN MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING HEPATIC AND RENAL DISEASES 审中-公开
    在制造治疗或预防肝病和肾病的药物中使用罗斯玛酸

    公开(公告)号:US20100130604A1

    公开(公告)日:2010-05-27

    申请号:US12306893

    申请日:2007-06-29

    IPC分类号: A61K31/216 C07C69/73

    摘要: The present invention demonstrates through many experiments that Rosmarinic acid (RA) can inhibit the expression of connective tissue growth factor (CTGF) and therefore is useful for the prevention or treatment of hepatofibrosis and nephrofibrosis. Based on this, the present invention provides novel uses of RA and pharmaceutical compositions comprising the same in the manufacture of medicaments useful for the prevention or treatment of chronic hepatitis, CRF, and diabetic nephropathy.

    摘要翻译: 本发明通过许多实验证明迷迭香酸(RA)可以抑制结缔组织生长因子(CTGF)的表达,因此可用于预防或治疗肝纤维化和肾纤维化。 基于此,本发明提供了RA及其制备方法的新用途,该药物组合物包含其用于制备可用于预防或治疗慢性肝炎,CRF和糖尿病性肾病的药物。